Concepedia

Publication | Open Access

Recombinant Growth Hormone Therapy in Patients With Ischemic Cardiomyopathy

DOIFull Paper Access

138

Citations

6

References

1999

Year

Sabine Genth‐Zotz, Rainer J. Zotz, Stefanie Geil, Thomas Voigtländer, Jürgen Meyer, Harald Darius
Circulation

Abstract

The administration of rhGH for 3 months in patients with ischemic cardiomyopathy results in significant improvement in hemodynamics and clinical function. The attenuation of left ventricular remodeling persisted 3 months after discontinuation of treatment.

References

YearCitations

Page 1